First FDA-Approved 3D Printed Medicine Becomes Available

Aprecia Pharmaceuticals announced that SPRITAMĀ® (levetiracetam) tablets, for oral suspension, is now available as an adjunctive therapy in the treatment of partial onset seizures, myoclonic seizures and primary generalized tonic-clonic seizures.

SPRITAM is the first prescription drug product approved by the U.S. Food and Drug Administration (FDA) that is manufactured using 3D printing technology. Continue reading “First FDA-Approved 3D Printed Medicine Becomes Available”